MoneyWorks4Me

The total revenue surged to Rs. 9305.00 millions, up 165.02% for the September 2023 quarter as against Rs. 3511.00 millions during the year-ago period.The Total revenue for the quarter ended September 2023 of  Rs. 3602.00  millions  grew by 855.44% from Rs. 377.00 millions.Operating profit surged to 4670.00 millions from the corresponding previous quarter of 863.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9305.00 3511.00 165.02 19788.00 11568.00 71.06 23510.00 17678.00 32.99
Other Income 247.00 162.00 52.47 393.00 494.00 -20.45 855.00 946.00 -9.62
PBIDT 4670.00 863.00 441.14 9853.00 4989.00 97.49 9302.00 3076.00 202.41
Interest 30.00 17.00 76.47 62.00 44.00 40.91 86.00 133.00 -35.34
PBDT 4640.00 846.00 448.46 9791.00 4945.00 98.00 9216.00 2943.00 213.15
Depreciation 400.00 383.00 4.44 799.00 752.00 6.25 1509.00 1384.00 9.03
PBT 4240.00 463.00 815.77 8992.00 4193.00 114.45 7707.00 1559.00 394.36
TAX 638.00 86.00 641.86 1337.00 736.00 81.66 1336.00 168.00 695.24
Deferred Tax -115.00 -6.00 1816.67 -254.00 -16.00 1487.50 5.00 -157.00 -103.18
PAT 3602.00 377.00 855.44 7655.00 3457.00 121.43 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 50.19 24.58 104.18 49.79 43.13 15.45 39.57 17.40 127.39
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..